Effect of the IL-6 promoter polymorphism -174 G/C on risk and outcome of pneumonia (2008)
Martín-Loeches, I, Violan, J Solé, Blanquer, J, Aspa, J, Gallego, C Rodríguez, De Castro, F Rodríguez, ...
No abstract available.
Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome
Menendez, R, Torres, A, Zalacain, R, Aspa, J, Martin, V, Borderias, L, ...
Background: An inadequate response to initial empirical treatment of community acquired pneumonia (CAP) represents a challenge for clinicians and requires early identification and intervention. A...